TrialBlood2012

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.

James N Kochenderfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.